London Daily

Focus on the big picture.
Tuesday, Nov 25, 2025

UK approves another antibody treatment for Covid

UK approves another antibody treatment for Covid

The UK has approved another antibody treatment for people with Covid that cuts the risk of severe illness.

It's called sotrovimab, and scientists say preliminary checks suggest it should work well even against new variants such as Omicron.

The drug, given in a drip into a vein, binds to the virus to stop it entering our cells.

In a clinical trial, a single dose reduced the risk of hospitalisation and death by 79% in high risk adults.

It is the second drug of its kind - a monoclonal antibody treatment - that UK regulators have approved.

Both sotrovimab and the other approved antibody treatment, ronapreve, are most effective when taken during the early stages of infection. The Medicines and Healthcare products Regulatory Agency (MHRA) recommends they are used within five days of someone getting symptoms.

Dr June Raine, MHRA chief executive, said: "This is yet another therapeutic that has been shown to be effective at protecting those most vulnerable to Covid-19, and signals another significant step forward in our fight against this devastating disease."

Drug company GSK, which made sotrovimab (Xevudy), says it has run some early tests in the lab to see how well the treatment fares against the new, heavily mutated Covid variant Omicron that is now spreading around the world.

More checks are needed, but researchers say the drug targets a part of the spike protein of the virus that has not yet undergone big changes or mutations, meaning it should work well.

Henny Braund, chief executive of cancer charity Anthony Nolan, said: "This is positive news for blood cancer patients, who we know are less likely to be protected from Covid-19 vaccines than the wider population. It is particularly important that patients can access this treatment immediately, if they contract the virus, and there is clear guidance for doctors on making it available."

What treatments do we have against Covid?


Aside from vaccines that are designed to help prevent infections happening in the first place, as well as cut the risk of getting very ill, there are a few different types of treatments for Covid.

They fall into three main categories:

* Antibodies that can target the virus, taken from either survivors' blood plasma or made in a lab (such as sotrovimab and ronapreve)

* Antiviral pills, such as molnupiravir, that directly affect the coronavirus's ability to thrive inside the body

* Drugs, such as dexamethasone, that calm the immune system

Most people who have Covid do not need any treatment and will recover within a few weeks. You may be able to look after yourself at home. Some of the same things you do to feel better if you have the flu - resting, drinking enough fluids and taking paracetamol or ibuprofen - can help.

If you become more unwell then you should seek medical help.

People who think they may have Covid should get a test and self-isolate to help stop the virus spreading.

Newsletter

Related Articles

0:00
0:00
Close
UK Economy Stalls as Reeves Faces First Budget Test
UK Economy’s Weak Start Adds Pressure on Prime Minister Starmer
UK Government Acknowledges Billionaire Exodus Amid Tax Rise Concerns
UK Budget 2025: Markets Brace as Chancellor Faces Fiscal Tightrope
UK Unveils Strategic Plan to Secure Critical Mineral Supply Chains
UK Taskforce Calls for Radical Reset of Nuclear Regulation to Cut Costs and Accelerate Build
UK Government Launches Consultation on Major Overhaul of Settlement Rules
Google Struggles to Meet AI Demand as Infrastructure, Energy and Supply-Chain Gaps Deepen
Car Parts Leader Warns Europe Faces Heavy Job Losses in ‘Darwinian’ Auto Shake-Out
Arsenal Move Six Points Clear After Eze’s Historic Hat-Trick in Derby Rout
Wealthy New Yorkers Weigh Second Homes as the ‘Mamdani Effect’ Ripples Through Luxury Markets
Families Accuse OpenAI of Enabling ‘AI-Driven Delusions’ After Multiple Suicides
UK Unveils Critical-Minerals Strategy to Break China Supply-Chain Grip
Taylor Swift’s “The Fate of Ophelia” Extends U.K. No. 1 Run to Five Weeks
UK VPN Sign-Ups Surge by Over 1,400 % as Age-Verification Law Takes Effect
Former MEP Nathan Gill Jailed for Over Ten Years After Taking Pro-Russia Bribes
Majority of UK Entrepreneurs Regard Government as ‘Anti-Business’, Survey Shows
UK’s Starmer and US President Trump Align as Geneva Talks Probe Ukraine Peace Plan
UK Prime Minister Signals Former Prince Andrew Should Testify to US Epstein Inquiry
Royal Navy Deploys HMS Severn to Shadow Russian Corvette and Tanker Off UK Coast
China’s Wedding Boom: Nightclubs, Mountains and a Demographic Reset
Fugees Founding Member Pras Michel Sentenced to 14 Years in High-Profile US Foreign Influence Case
WhatsApp’s Unexpected Rise Reshapes American Messaging Habits
United States: Judge Dressed Up as Elvis During Hearings – and Was Forced to Resign
Johnson Blasts ‘Incoherent’ Covid Inquiry Findings Amid Report’s Harsh Critique of His Government
Lord Rothermere Secures £500 Million Deal to Acquire Telegraph Titles
Maduro Tightens Security Measures as U.S. Strike Threat Intensifies
U.S. Envoys Deliver Ultimatum to Ukraine: Sign Peace Deal by Thursday or Risk Losing American Support
Zelenskyy Signals Progress Toward Ending the War: ‘One of the Hardest Moments in History’ (end of his business model?)
U.S. Issues Alert Declaring Venezuelan Airspace a Hazard Due to Escalating Security Conditions
The U.S. State Department Announces That Mass Migration Constitutes an Existential Threat to Western Civilization and Undermines the Stability of Key American Allies
Students Challenge AI-Driven Teaching at University of Staffordshire
Pikeville Medical Center Partners with UK’s Golisano Children’s Network to Expand Pediatric Care
Germany, France and UK Confirm Full Support for Ukraine in US-Backed Security Plan
UK Low-Traffic Neighbourhoods Face Rising Backlash as Pandemic Schemes Unravel
UK Records Coldest Night of Autumn as Sub-Zero Conditions Sweep the Country
UK at Risk of Losing International Doctors as Workforce Exodus Grows, Regulator Warns
ASU Launches ASU London, Extending Its Innovation Brand to the UK Education Market
UK Prime Minister Keir Starmer to Visit China in January as Diplomatic Reset Accelerates
Google Launches Voluntary Buyouts for UK Staff Amid AI-Driven Company Realignment
UK braces for freezing snap as snow and ice warnings escalate
Majority of UK Novelists Fear AI Could Displace Their Work, Cambridge Study Finds
UK's Carrier Strike Group Achieves Full Operational Capability During NATO Drill in Mediterranean
Trump and Mamdani to Meet at the White House: “The Communist Asked”
Nvidia Again Beats Forecasts, Shares Jump in After-Hours Trading
Wintry Conditions Persist Along UK Coasts After Up to Seven Centimetres of Snow
UK Inflation Eases to 3.6 % in October, Opening Door for Rate Cut
UK Accelerates Munitions Factory Build-Out to Reinforce Warfighting Readiness
UK Consumer Optimism Plunges Ahead of November Budget
A Decade of Innovation Stagnation at Apple: The Cook Era Critique
×